Liu, Z., Zhang, H., Ma, S., Cui, S., Ye, J., Ou, L., Lei, R., Peng, P. (2026). Neoadjuvant pyrotinib plus trastuzumab combined with chemotherapy for HER2+/HR+ early breast cancer: A multicenter phase 2 trail.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e12641